Clinical Trial Detail

NCT ID NCT03048500
Title Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

lung non-small cell carcinoma

Therapies

Metformin + Nivolumab

Age Groups: adult senior

No variant requirements are available.